PRVA earnings: real EPS beat/miss history, analyst consensus Buy, P/E 143.41. Updated 2026-07-23.
Privia Health Group (PRVA) Research Hub
Privia Health Group (PRVA) trades on NASDAQ, US in the Healthcare (Medical - Healthcare Information Services) sector. As of 2026-09-11, shares last closed at 20.42 USD (0.00%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 143.41, market cap 3.21B. This hub links to the full technical, earnings and options research available for PRVA.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Healthcare Information Services) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 20.42 USD (0.00%) |
| 52-week range | 19.7 USD – 28.82 USD |
| Trend regime | Range |
| 14-day RSI | 9.2 (Oversold) |
| Trailing P/E | 143.41 |
| Market cap | 3.21B |
| Dividend yield | 0.00% |
Available research for PRVA
Covered Call on PRVA: how it works, illustrative setup around the real 20.42 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on PRVA: how it works, illustrative setup around the real 20.42 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on PRVA: how it works, illustrative setup around the real 20.42 USD price, max profit/loss, breakeven and when to use it. Educational.
PRVA technical analysis: range, last 20.42 USD, RSI 9.2, 52w range 19.7 USD–28.82 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is PRVA in?
Privia Health Group (PRVA) is classified under Healthcare (Medical - Healthcare Information Services), listed on NASDAQ, US.
Is PRVA in an uptrend or downtrend?
As of 2026-09-11, PRVA is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is PRVA's trailing P/E ratio?
PRVA's trailing P/E is 143.41, with a market cap of 3.21B. See the earnings research page for full valuation detail.